A detailed history of Franklin Resources Inc transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Franklin Resources Inc holds 36,496 shares of BPMC stock, worth $3.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,496
Previous 29,291 24.6%
Holding current value
$3.26 Million
Previous $2.78 Million 41.58%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$85.18 - $108.78 $613,721 - $783,759
7,205 Added 24.6%
36,496 $3.93 Million
Q1 2024

May 13, 2024

BUY
$73.17 - $99.79 $1.75 Million - $2.39 Million
23,951 Added 448.52%
29,291 $2.78 Million
Q4 2023

Feb 09, 2024

BUY
$43.96 - $92.84 $234,746 - $495,765
5,340 New
5,340 $492,000
Q2 2022

Aug 11, 2022

SELL
$45.23 - $70.15 $18.7 Million - $29 Million
-413,665 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$54.1 - $110.08 $377,672 - $768,468
-6,981 Reduced 1.66%
413,665 $26.4 Million
Q4 2021

Feb 11, 2022

SELL
$94.25 - $115.99 $6.75 Million - $8.31 Million
-71,641 Reduced 14.55%
420,646 $45.1 Million
Q3 2021

Nov 12, 2021

SELL
$80.98 - $109.47 $1.52 Million - $2.05 Million
-18,734 Reduced 3.67%
492,287 $50.6 Million
Q2 2021

Aug 13, 2021

BUY
$82.78 - $101.0 $40,396 - $49,288
488 Added 0.1%
511,021 $44.9 Million
Q1 2021

May 13, 2021

SELL
$90.71 - $108.28 $16,599 - $19,815
-183 Reduced 0.04%
510,533 $49.6 Million
Q4 2020

Feb 10, 2021

SELL
$92.08 - $124.48 $34,530 - $46,680
-375 Reduced 0.07%
510,716 $57.3 Million
Q3 2020

Nov 12, 2020

BUY
$66.45 - $92.7 $7.58 Million - $10.6 Million
114,067 Added 28.73%
511,091 $47.4 Million
Q2 2020

Aug 13, 2020

BUY
$57.09 - $79.27 $17 Million - $23.5 Million
296,941 Added 296.69%
397,024 $31.1 Million
Q1 2020

May 13, 2020

BUY
$48.11 - $82.22 $4.81 Million - $8.23 Million
100,083 New
100,083 $5.85 Million

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.33B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.